In every issue of POZ, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
In this essay, Tom Perrault recounts his journey toward hopefully controlling HIV without medication.
Participants will first receive a therapeutic vaccine to enhance CD8 T cells’ ability to kill virus-infected cells.
After advances in HIV therapy, long-acting antiretrovirals and long-term remission are the next frontiers.
People living with HIV are meeting the accelerating challenges of the opioid epidemic.
This quick-reference chart compares antiretroviral (ARV) options for the treatment of HIV, including adult dosing and dietary restrictions.
I have always believed that HIV would someday be cured.
The International Association of Providers of AIDS Care urges further action on global HIV advocacy.
In ViiV’s new initiative, Black women offer stigma-free language.
Cultural influencers promote HIV prevention.
Danny Roberts returns in New Orleans Homecoming and battles HIV stigma.
Global groups unite to deliver meds.
Researchers reach out to faith communities.
These dates represent milestones in the HIV epidemic. Visit poz.com/aidsiseveryday to learn more about the history of HIV/AIDS.
POZ blogger Richard JMV shares yet another milestone in their journey living with HIV. Read an edited excerpt.
NMAC executive director Paul Kawata shared how good it felt to be back at the 2022 Biomedical HIV Prevention Summit
Middle-aged men living with HIV may have low testosterone levels more commonly seen in older men.
A nice-looking butt isn’t the only reason to add leg strengthening exercises to your fitness routine
Hormones can improve quality of life in menopause, but women aging with HIV aren’t getting the support they need.
The Biden administration unveiled the country’s inaugural National Drug Control Strategy in April.
Pre-exposure prophylaxis (PrEP) prescriptions are supposed to be free under the Affordable Care Act (ACA), but barriers persist.
The Food and Drug Administration recently extended the indication for Cabenuva to include adolescents ages 12 and up.
Broadly neutralizing antibodies (bnAbs) can delay HIV rebound and even lead to long-term remission.
Lung cancer screening, which can detect tumors at an earlier stage, may be even more important for people living with HIV.
Study participation can be a gateway to better therapies for yourself and others.
Be bold and experiment—it will still be delicious!
Generally speaking, there are two types of exercise.
Steven Deeks, a pioneer in HIV cure research, is now tackling a new challenge: long COVID.
When disaster strikes, will you be ready?
Read the digital edition!